Da Vinci Robot Executives Sell Shares According to Pre-Established Plan

Intuitive Surgical (NASDAQ: ISRG) executives disclosed that they have been systematically selling shares in recent weeks under stock option exercises and Rule 10b5-1 trading plans. On June 1, a da Vinci platform executive exercised options to acquire approximately 5,600 shares and then sold a similar amount the same day at about $420 per share, netting roughly $2.4 million; the executive continues to hold several thousand shares. In mid-May, both the chief legal officer and the head of manufacturing and supply chain sold relatively small positions—hundreds and dozens of shares, respectively—under prearranged trading plans, while retaining holdings in the thousands.

In its April 21 release of first-quarter 2026 results, the company reported revenue of about $2.77 billion and net income of $822 million, sustaining double-digit growth compared with the prior year. In May, Intuitive announced over 100 updates to its da Vinci 5 robotic surgery system and plans to extend instrument usage periods. On June 9, Zacks upgraded its rating on the company to “Buy,” refocusing investor attention on the platform’s growth prospects and performance momentum.

Intuitive Surgical, known for its da Vinci minimally invasive surgical robots, has delivered more than 10,000 systems to hospitals across over 70 countries and commands approximately a 60–70% share of the global surgical robotics market. A significant portion of its revenue comes from surgical instruments, consumables, and services. In 2025, the company’s annual revenue reached about $10 billion, driven by the expanding adoption of robotic surgery.